170 related articles for article (PubMed ID: 35410836)
1. DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast.
Zhao H; Ming X; Yang Z
Asian J Surg; 2022 Oct; 45(10):1855-1856. PubMed ID: 35410836
[No Abstract] [Full Text] [Related]
2. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
6. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
7. A practical approach to breast ductal carcinoma in situ and tumors with an extensive intraductal component.
King JM
Pathology; 1994 Apr; 26(2):90-3. PubMed ID: 8090601
[TBL] [Abstract][Full Text] [Related]
8. Goldilocks and margins for DCIS: Identifying "just right".
Jagsi R
Pract Radiat Oncol; 2016; 6(5):296-297. PubMed ID: 27538811
[No Abstract] [Full Text] [Related]
9. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
10. Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view.
Mai KT; Perkins DG; Mirsky D
Breast J; 2003; 9(1):33-8. PubMed ID: 12558668
[TBL] [Abstract][Full Text] [Related]
11. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
[TBL] [Abstract][Full Text] [Related]
12. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
13. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
Liu TT; Li XF; Wang L; Yang JL
Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
[TBL] [Abstract][Full Text] [Related]
14. Clinic-Pathological Features of Breast Ductal Carcinoma
Zheng J; Zhou T; Li F; Shi J; Zhang L
Cancer Invest; 2020 Feb; 38(2):113-121. PubMed ID: 31939679
[No Abstract] [Full Text] [Related]
15. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
16. Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast.
Fisher ER
CA Cancer J Clin; 1997; 47(1):52-64. PubMed ID: 8996078
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma in sclerosing adenosis: a clinicopathological and immunophenotypical analysis on 206 lesions.
Yu BH; Tang SX; Xu XL; Cheng YF; Bi R; Shui RH; Tu XY; Lu HF; Zhou XY; Yang WT
J Clin Pathol; 2018 Jun; 71(6):546-553. PubMed ID: 29436376
[TBL] [Abstract][Full Text] [Related]
18. Potential of specimen diffusion-weighted imaging to assess the intraoperative margin for ductal carcinoma in situ and invasive breast cancer.
Mori N; Mugikura S; Takase K
J Surg Oncol; 2023 Mar; 127(3):514-516. PubMed ID: 36394392
[No Abstract] [Full Text] [Related]
19. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
20. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]